Disruption in the diabetic device care market

Utkarsh Ojha,1 Raihan Mohammed2 1Faculty of Medicine, Imperial College School of Medicine, Imperial College London, London, UK; 2Department of Medicine, University of Cambridge, Cambridge, UK Abstract: As diabetes mellitus (DM) has approached pandemic proportions, the pressure for effective glycemic...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ojha U, Mohammed R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Medical Devices Medical Technology Innovation Disruption Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/669057aca37c4b84b132004ba35bae5d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:669057aca37c4b84b132004ba35bae5d
record_format	dspace
spelling	oai:doaj.org-article:669057aca37c4b84b132004ba35bae5d2021-12-02T05:19:44ZDisruption in the diabetic device care market1179-1470https://doaj.org/article/669057aca37c4b84b132004ba35bae5d2018-02-01T00:00:00Zhttps://www.dovepress.com/disruption-in-the-diabetic-device-care-market-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Utkarsh Ojha,1 Raihan Mohammed2 1Faculty of Medicine, Imperial College School of Medicine, Imperial College London, London, UK; 2Department of Medicine, University of Cambridge, Cambridge, UK Abstract: As diabetes mellitus (DM) has approached pandemic proportions, the pressure for effective glycemic management is mounting. The starting point for managing and living well with DM involves early diagnosis and monitoring blood glucose levels. Therefore, self-monitoring of blood glucose (SMBG) can help patients maintain their blood glucose levels within the appropriate range. The general principle behind the current SMBG method involves a finger prick test to obtain a blood drop, which is applied onto a reagent strip and read by an automated device. Novel techniques are currently under evaluation to create the next generation of painless and accurate glucose monitoring for DM. We began by outlining how the emerging technology of the noninvasive glucose monitoring devices (NIGMDs) provides both economic and clinical benefits for health systems and patients. We further explored the engineering and techniques behind these upcoming devices. Finally, we evaluated how the NIGMDs disrupt the diabetic device care market and drive health care consumerism. We postulated that the NIGMDs play a pivotal role in the implementation of next generation of diabetes prevention strategies. Keywords: medical devices, medical technology, diabetes management, innovationOjha UMohammed RDove Medical PressarticleMedical DevicesMedical TechnologyInnovationDisruptionMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 11, Pp 51-56 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medical Devices Medical Technology Innovation Disruption Medical technology R855-855.5
spellingShingle	Medical Devices Medical Technology Innovation Disruption Medical technology R855-855.5 Ojha U Mohammed R Disruption in the diabetic device care market
description	Utkarsh Ojha,1 Raihan Mohammed2 1Faculty of Medicine, Imperial College School of Medicine, Imperial College London, London, UK; 2Department of Medicine, University of Cambridge, Cambridge, UK Abstract: As diabetes mellitus (DM) has approached pandemic proportions, the pressure for effective glycemic management is mounting. The starting point for managing and living well with DM involves early diagnosis and monitoring blood glucose levels. Therefore, self-monitoring of blood glucose (SMBG) can help patients maintain their blood glucose levels within the appropriate range. The general principle behind the current SMBG method involves a finger prick test to obtain a blood drop, which is applied onto a reagent strip and read by an automated device. Novel techniques are currently under evaluation to create the next generation of painless and accurate glucose monitoring for DM. We began by outlining how the emerging technology of the noninvasive glucose monitoring devices (NIGMDs) provides both economic and clinical benefits for health systems and patients. We further explored the engineering and techniques behind these upcoming devices. Finally, we evaluated how the NIGMDs disrupt the diabetic device care market and drive health care consumerism. We postulated that the NIGMDs play a pivotal role in the implementation of next generation of diabetes prevention strategies. Keywords: medical devices, medical technology, diabetes management, innovation
format	article
author	Ojha U Mohammed R
author_facet	Ojha U Mohammed R
author_sort	Ojha U
title	Disruption in the diabetic device care market
title_short	Disruption in the diabetic device care market
title_full	Disruption in the diabetic device care market
title_fullStr	Disruption in the diabetic device care market
title_full_unstemmed	Disruption in the diabetic device care market
title_sort	disruption in the diabetic device care market
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/669057aca37c4b84b132004ba35bae5d
work_keys_str_mv	AT ojhau disruptioninthediabeticdevicecaremarket AT mohammedr disruptioninthediabeticdevicecaremarket
_version_	1718400473748209664

Disruption in the diabetic device care market

Ejemplares similares